Plasticell Limited is a biotechnology company founded in 2002. The company specializes in developing novel therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology. Plasticell's innovative cell-based combinatorial screening technology allows them to develop optimized protocols for cell expansion, cell differentiation, gene transduction, biomolecule production, as well as the provision of human cells for use in drug discovery. Their pipeline includes advanced cell and gene therapies, along with drugs discovered by screening rare human cell types derived from stem cells. Plasticell recently received a grant investment on 08 August 2023, highlighting investor interest in their innovative approach. For more details, visit their website www.plasticell.co.uk.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | Unknown | - | 08 Aug 2023 | |
| Venture - Series Unknown | Unknown | - | 28 May 2021 | |
| Venture - Series Unknown | Unknown | - | 31 Oct 2018 | |
| Grant | Unknown | - | 18 Apr 2017 | |
| Venture - Series Unknown | Unknown | - | 07 Nov 2016 |
No recent news or press coverage available for Plasticell Limited.
We care about your data, and we'd love to use cookies make your experience better.
